Novo Nordisk A/S (NYSE:NVO) said it had become aware of several hundred units of Ozempic (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized supply chain in the U.S. The ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...

Individuals in possession of a counterfeit Ozempic product are encouraged to report it to Novo Nordisk customer care at 1-800-727-6500 during business hours. Additionally, any adverse events should be ...

Novo Nordisk notified the Food and Drug Administration about several hundred units of fake semaglutide 1.0 mg in the US drug ...

Aussies have been warned to think before they jab, with more counterfeit Ozempic-labelled products seized at the border.

The Centres for Medicare and Medicaid Services on Friday said that it did not move forward with a proposal put forward by the ...

Novo Nordisk has made its smart insulin pens available ... The new devices – NovoPen 6 and NovoPen Echo Plus – are insulin self-injection pens that record information such as when and how ...

The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.

Novo Nordisk is expanding its prospects in obesity ... a product administered in single-use, pre-filled injection pens. The new lower cash price for Wegovy covers all doses of the drug.

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...

Novo Nordisk A/S ... The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin ...